Research study Program year 2025 Source: CMS Open Payments

An Exploratory Phase 1B, Multicenter, Randomized, Open-Label Study to

Research payments

$94,112

12 payments

Through program year 2025, $94,112 in research payments was reported against An Exploratory Phase 1B, Multicenter, Randomized, Open-Label Study to, across 12 payments, paid by ViiV Healthcare Company.

Paid by: ViiV Healthcare Company
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$94,112	12

Breakdown

Who paid Research payments · program year 2025

ViiV Healthcare Company $94,112 12 payments

Who received the money Research payments · program year 2025

Wash U Infectious Disease Organisation paid for research $28,703 2 payments
Midway Immunology And Research Center Organisation paid for research $20,708 4 payments
Kansas City Care Clinic Organisation paid for research $17,889 3 payments
Orlando Immunology Center Organisation paid for research $15,100 1 payment
Uc San Diego Med Ct Op Organisation paid for research $7,203 1 payment
University of Cincinnati Organisation paid for research $4,509 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.